RT Journal Article
T1 SEOM clinical guidelines on cardiovascular toxicity (2018).
A1 Virizuela, J A
A1 García, A M
A1 de Las Peñas, R
A1 Santaballa, A
A1 Andrés, R
A1 Beato, C
A1 de la Cruz, S
A1 Gavilá, J
A1 González-Santiago, S
A1 Fernández, T L
K1 Cancer
K1 Cardiotoxicity
K1 Chemotherapy
K1 Early detection
K1 Risk assessment
AB One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients.
YR 2019
FD 2019-01-09
LK http://hdl.handle.net/10668/13408
UL http://hdl.handle.net/10668/13408
LA en
DS RISalud
RD Apr 18, 2025